James McCracken (@capitaljim) 's Twitter Profile
James McCracken

@capitaljim

Medical Oncologist @PeterMac @Epworth & PhD candidate @UniMelb | Breast & GI cancer | Father, husband, cyclist, dog lover, armchair footballer. Views my own.

ID: 269189075

calendar_today20-03-2011 07:56:56

241 Tweet

467 Followers

1,1K Following

James McCracken (@capitaljim) 's Twitter Profile Photo

Terrible, terrible service from iiNet. Moved house on 22nd of December, have been trying to relocate my service since 15th of December, a month later still no internet. Notably, and despite Christmas, event local council has moved faster in issuing new parking permits.

OncLive.com (@onclive) 's Twitter Profile Photo

Continued approval for the combination of atezolizumab and paclitaxel in treatment-naïve patients with inoperable locally advanced or metastatic triple-negative breast cancer is dependent on proven benefit in additional clinical trials. U.S. FDA #FDA #bcsm ow.ly/5W7f50BljyI

FabriceAndre (@fandremd) 's Twitter Profile Photo

31% OR to sacituzumab govitecan in pts with HR+/Her2- pretreated mBC. One more data suggesting that new generation ADC is going to be transformative for patients with BC. I look forward to see ADCs in early stage BC, combo w IO and in selected pts annalsofoncology.org/article/S0923-…

James McCracken (@capitaljim) 's Twitter Profile Photo

Impassion 031 is positive, with the addition of atezo to neoadjuvant taxane and anthracycline NACT. Interesting data on the back of impassion 131 (and odd statistical analysis).

James McCracken (@capitaljim) 's Twitter Profile Photo

Two of my favourites, Ben Solomon & Norman Swan discussing updates in lung cancer treatment. Find a spot in the sun with a G&T and enjoy this (socially distanced of course)! #Cancer #lungcancer #iwannabelikeben